All News

Fatigue is one of the most common complaints of patients.

Complementary therapies can make a difference in the cancer journey, and now we have to get oncologists to accept them

Combined modality treatment (CMT) could be considered a first course of treatment for patients with muscle-invasive bladder cancer, according to the authors of a recent study published in the International Journal of Radiation Oncology.

Patients with squamous cell carcinoma of the head and neck (SCCHC) and those with melanoma saw some promising activity with the drug combination of epacadostat and Opdivo (nivolumab), according to findings from the phase 1/2 ECHO-204 study presented at the 2017 ASCO Annual Meeting.

Little did I know, yoga would play a huge role in my life and recovery from breast cancer.

How your response in a medical crisis can impact loved ones

Maybe they'll be able to put the big girl pants on when life throws it's curve balls.

Even cereals with healthy-sounding names don’t quite make the mark.

A new study published in Cancer Medicine examined the long-term health-related effects of definitive treatment for patients with localized prostate cancer and found that they continue more than 10 years after treatment.

Taking time to show apprecitaion and graitude to the giants of oncology and all that they do

Some newly diagnosed patients with prostate cancer reduced their risk of death with earlier use of Zytiga, according to two trials presented at the ASCO Annual Meeting.

Opdivo (nivolumab) plus Yervoy (ipilimumab) demonstrated a response in some patients with melanoma brain metastases, according to a recent study presented at ASCO.

How writing helped me deal with the effects of cancer.

Soy remains an important and somewhat contentious health topic.

Chemobrain is more than being lazy or forgetful sometimes.

The psychotherapty known as CALM has been shown to ease depression and distress in patients with advanced cancer.

A recent study proved an online program to be helpful in reducing anxiety in many newly diagnosed patients.

Becoming pregnant does not increase a woman's chance of having her breast cancer recur, according to a recent study presented at ASCO.

VYXEOS (CPX-351), a novel injection, was granted a new drug application (NDA) by the Food and Drug Administration (FDA), granting the drug a priority review for the treatment of acute myeloid leukemia (AML), according to Jazz Pharmaceuticals, the producer of the drug.

Researchers found that nearly 75 percent of sunscreen products contain less SPF than labeled, and the Environmental Working Group (EWG) is working to have that changed.

The fear of metastatic cancer is a constant challenge. Even years after an initial diagnosis, cancer can return.

According to results from the phase 3 RANGE trial, the addition of Cyramza (ramucirumab) to docetaxel resulted in improved progression-free survival for patients with previously treated locally advanced or unresectable or metastatic urothelial carcinoma.

Actress Marilu Henner spoke with CURE about her husband's journey with cancer and the importance of having the difficult conversations.

The uncertainty that arises from an ovarian cancer diagnosis can be very stressful. A recent study examined these feelings that many women with the disease are experiencing.

We’re all so busy and stressed with personal, medical, financial and professional responsibilities. This stress can have a real biological effect on our bodies that we should try to manage.

Try on some new healthy habits without grappling with a daunting obscure health recommendation to eat more whole grains.

Nobody knows you like you know you, and don’t let anyone tell you different.

Patients with in immunotherapy-naïve and pretreated patients with advanced melanoma saw a 50 percent overall response rate (ORR) when adding a formulation of the Coxsackievirus A21 (CVA21; CAVATAK®) to Yervoy (ipilimumab) – a combination which was well-tolerated.

What stands in the way of patient-physician communications and how can we get around these barriers?